Bachem Holding AG Logo

Bachem Holding AG

A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.

BANB | SW

Overview

Corporate Details

ISIN(s):
CH1176493729 (+1 more)
LEI:
506700S81111XI7TG884
Country:
Switzerland
Address:
Hauptstrasse 144, 4416 Bubendorf

Description

Bachem is a technology company specializing in the development and manufacturing of peptides and oligonucleotides. As a contract development and manufacturing organization (CDMO), it provides a comprehensive range of products and services to the pharmaceutical and biotechnology industries. The company supports clients throughout the entire product lifecycle, from research and clinical development to commercial application. Its portfolio includes active pharmaceutical ingredients (APIs) as New Chemical Entities (NCEs) and generics, as well as an extensive catalog of research-grade products such as catalog peptides, amino acid derivatives, and custom synthesis services. Bachem also offers its expertise for cosmetic and diagnostic applications.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 01:00
Anne-Kathrin Stoller to become new CEO at Bachem
English 4.3 KB
2025-10-31 01:00
Anne-Kathrin Stoller wird neue CEO bei Bachem
German 4.8 KB
2025-10-23 02:00
Bachem announces progress in Building K start-up and expansion of its site in V…
English 3.6 KB
2025-10-23 02:00
Bachem gibt Fortschritte bei der Betriebsaufnahme von Gebäude K und die Erweite…
German 4.1 KB
2025-08-20 02:00
Bachem expands Corporate Executive Committee to include Chief Operations Office…
English 5.3 KB
2025-08-20 02:00
Bachem erweitert Konzernleitung um die Rolle des Chief Operations Officer
German 5.8 KB
2025-07-24 02:00
Bachem shows strong growth in the first half of 2025
English 10.8 KB
2025-07-24 02:00
Bachem mit starkem Wachstum im ersten Halbjahr 2025
German 12.1 KB
2025-06-03 02:00
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
English 4.7 KB
2025-06-03 02:00
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
German 7.7 KB
2025-02-27 01:00
Bachem increases sales and profitability
English 9.7 KB
2025-02-27 01:00
Bachem erhöht Umsatz und Profitabilität
German 11.3 KB
2024-07-25 02:00
Bachem with slight sales growth in the first half of 2024. Outlook confirmed fo…
English 7.9 KB
2024-07-25 02:00
Bachem mit leichtem Umsatzplus im ersten Halbjahr 2024. Ausblick für das Gesam…
German 8.5 KB
2024-05-28 02:00
Incident on construction site of Bachem in Bubendorf
English 2.9 KB

Automate Your Workflow. Get a real-time feed of all Bachem Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bachem Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bachem Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-06 N/A Non-Executive member Buy None 30,315.25 CHF

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.